Tapewire

Nasdaq · USD

CGEM

Cullinan Therapeutics, Inc.

Export transactions ↓
Tapewire entity
4766
SEC CIK
0001789972
Parsed reports
252

Last 12 months

Inside the activity.

0 purchase rows · 28 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202507
Jan 202601
Feb 2026013
Mar 202601
Apr 202600
May 202602
Jun 202600
Jul 202601
Aug 202601
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 18, 2023 Filed Dec 20, 2023 23:00 UTC
Michaelson JenniferChief Scientific Officer
SaleCommon Stock 238 $8.22 $1,956.36
Disclosure

SEC source: 0000950170-23-071988 · ownership.xml · nonDerivative · entry 1

Michaelson Jennifer · CIK 0001838061 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 88,727

F1 · shares: Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.

Read SEC document
December 18, 2023 Filed Dec 20, 2023 23:00 UTC
SUMER JACQUELYN LChief Legal Officer
SaleCommon Stock 290 $8.22 $2,383.80
Disclosure

SEC source: 0000950170-23-071986 · ownership.xml · nonDerivative · entry 1

SUMER JACQUELYN L · CIK 0001844824 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,533

F1 · shares: Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.

Read SEC document
December 18, 2023 Filed Dec 20, 2023 23:00 UTC
Trigilio JeffreyChief Financial Officer
SaleCommon Stock 398 $8.22 $3,271.56
Disclosure

SEC source: 0000950170-23-071985 · ownership.xml · nonDerivative · entry 1

Trigilio Jeffrey · CIK 0001838671 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 85,839

F1 · shares: Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.

Read SEC document
December 12, 2023 Filed Dec 14, 2023 01:00 UTC
Trigilio JeffreyChief Financial Officer
SaleCommon Stock 1,926 $7.81 $15,042.06
Disclosure

SEC source: 0000950170-23-070143 · ownership.xml · nonDerivative · entry 1

Trigilio Jeffrey · CIK 0001838671 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,237

F1 · shares: Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.

Read SEC document
December 12, 2023 Filed Dec 14, 2023 01:00 UTC
Michaelson JenniferChief Scientific Officer
SaleCommon Stock 1,068 $7.81 $8,341.08
Disclosure

SEC source: 0000950170-23-070142 · ownership.xml · nonDerivative · entry 1

Michaelson Jennifer · CIK 0001838061 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 88,965

F1 · shares: Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.

Read SEC document
June 30, 2023 Filed Jul 6, 2023 01:27 UTC
Trigilio JeffreyChief Financial Officer
GrantCommon Stock 2,340 $9.08 $21,247.20
Disclosure

SEC source: 0000950170-23-031858 · ownership.xml · nonDerivative · entry 1

Trigilio Jeffrey · CIK 0001838671 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 88,163

F1 · security: The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Issuer's 2021 Employee Stock Purchase Plan (the "ESPP"), for the purchase period of January 1, 2023 through June 30, 2023. This transaction is also exempt under Rule 16b-3(c).

F2 · price: In accordance with the ESPP, the shares were purchased based on 85% of the closing price of the Issuer's common stock on January 1, 2023.

Read SEC document
June 28, 2023 Filed Jun 29, 2023 20:59 UTC
AHMED NADIMDirector · President and CEO
SaleCommon Stock 759 $11.40 $8,652.60
Disclosure

SEC source: 0000950170-23-030805 · ownership.xml · nonDerivative · entry 1

AHMED NADIM · CIK 0001731193 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 115,822

F1 · shares: Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.

Read SEC document
June 20, 2023 Filed Jun 21, 2023 20:17 UTC
Jones Jeffrey AlanChief Medical Officer
SaleCommon Stock 387 $12.94 $5,007.78
Disclosure

SEC source: 0000950170-23-029161 · ownership.xml · nonDerivative · entry 1

Jones Jeffrey Alan · CIK 0001914647 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,437

F1 · shares: Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.

Read SEC document
June 20, 2023 Filed Jun 21, 2023 20:17 UTC
Michaelson JenniferChief Development Officer
SaleCommon Stock 238 $12.94 $3,079.72
Disclosure

SEC source: 0000950170-23-029160 · ownership.xml · nonDerivative · entry 1

Michaelson Jennifer · CIK 0001838061 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,033

F1 · shares: Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.

Read SEC document
June 20, 2023 Filed Jun 21, 2023 20:17 UTC
Trigilio JeffreyChief Financial Officer
SaleCommon Stock 399 $12.94 $5,163.06
Disclosure

SEC source: 0000950170-23-029158 · ownership.xml · nonDerivative · entry 1

Trigilio Jeffrey · CIK 0001838671 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 85,823

F1 · shares: Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.

Read SEC document
June 20, 2023 Filed Jun 21, 2023 20:17 UTC
SUMER JACQUELYN LChief Legal Officer
SaleCommon Stock 291 $12.94 $3,765.54
Disclosure

SEC source: 0000950170-23-029157 · ownership.xml · nonDerivative · entry 1

SUMER JACQUELYN L · CIK 0001844824 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,823

F1 · shares: Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.

Read SEC document
June 12, 2023 Filed Jun 14, 2023 20:35 UTC
Trigilio JeffreyChief Financial Officer
SaleCommon Stock 319 $13.11 $4,182.09
Disclosure

SEC source: 0000950170-23-027985 · ownership.xml · nonDerivative · entry 1

Trigilio Jeffrey · CIK 0001838671 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,222

F1 · shares: Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.

Read SEC document
June 12, 2023 Filed Jun 14, 2023 20:35 UTC
Michaelson JenniferChief Development Officer
SaleCommon Stock 176 $13.11 $2,307.36
Disclosure

SEC source: 0000950170-23-027984 · ownership.xml · nonDerivative · entry 1

Michaelson Jennifer · CIK 0001838061 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,271

F1 · shares: Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.

Read SEC document
June 08, 2023 Filed Jun 12, 2023 21:57 UTC GrantStock Option (Right to Buy) · Derivative 18,450 $0.00 Strike: $13.00 $0.00
Disclosure

SEC source: 0000950170-23-027539 · ownership.xml · derivative · entry 1

Rosenberg Anthony · CIK 0001466175 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,450

Underlying: Common Stock · 18,450 shares

Expires 2033-06-07

F1 · derivative.exercise_date: The option represents a right to purchase a total of 18,450 shares of the Issuer's Common Stock, which shall vest in full on the earlier of (i) June 8, 2024 or (ii) the date of the Issuer's next annual meeting, subject to the Reporting Person's continued service as a director on such vesting date.

Read SEC document
June 08, 2023 Filed Jun 12, 2023 21:51 UTC GrantStock Option (Right to Buy) · Derivative 18,450 $0.00 Strike: $13.00 $0.00
Disclosure

SEC source: 0000950170-23-027538 · ownership.xml · derivative · entry 1

Webster Stephen W · CIK 0001438421 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,450

Underlying: Common Stock · 18,450 shares

Expires 2033-06-07

F1 · derivative.exercise_date: The option represents a right to purchase a total of 18,450 shares of the Issuer's Common Stock, which shall vest in full on the earlier of (i) June 8, 2024 or (ii) the date of the Issuer's next annual meeting, subject to the Reporting Person's continued service as a director on such vesting date.

Read SEC document
June 08, 2023 Filed Jun 12, 2023 17:58 UTC GrantStock Option (Right to Buy) · Derivative 18,450 $0.00 Strike: $13.00 $0.00
Disclosure

SEC source: 0000950170-23-027540 · ownership.xml · derivative · entry 1

Ebeling Thomas · CIK 0001297759 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,450

Underlying: Common Stock · 18,450 shares

Expires 2033-06-07

F1 · derivative.exercise_date: The option represents a right to purchase a total of 18,450 shares of the Issuer's Common Stock, which shall vest in full on the earlier of (i) June 8, 2024 or (ii) the date of the Issuer's next annual meeting, subject to the Reporting Person's continued service as a director on such vesting date.

Read SEC document
June 08, 2023 Filed Jun 12, 2023 21:50 UTC GrantStock Option (Right to Buy) · Derivative 18,450 $0.00 Strike: $13.00 $0.00
Disclosure

SEC source: 0000950170-23-027537 · ownership.xml · derivative · entry 1

Martin Anne-Marie · CIK 0001914495 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,450

Underlying: Common Stock · 18,450 shares

Expires 2033-06-07

F1 · derivative.exercise_date: The option represents a right to purchase a total of 18,450 shares of the Issuer's Common Stock, which shall vest in full on the earlier of (i) June 8, 2024 or (ii) the date of the Issuer's next annual meeting, subject to the Reporting Person's continued service as a director on such vesting date.

Read SEC document
June 07, 2023 Filed Jun 8, 2023 21:10 UTC
Michaelson JenniferChief Development Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 100 $0.00 Strike: $4.30 $0.00
Disclosure

SEC source: 0000950170-23-027063 · ownership.xml · derivative · entry 6

Michaelson Jennifer · CIK 0001838061 · Chief Development Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 188,593

Underlying: Common Stock · 100 shares

Expires 2030-10-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: 25% of the shares vested on July 4, 2020, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.

Read SEC document
June 07, 2023 Filed Jun 8, 2023 21:10 UTC
Michaelson JenniferChief Development Officer
SaleCommon Stock 100 $12.40 $1,240.00
Disclosure

SEC source: 0000950170-23-027063 · ownership.xml · nonDerivative · entry 4

Michaelson Jennifer · CIK 0001838061 · Chief Development Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 90,447

F1 · kind: Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on April 29, 2021, as amended on June 24, 2022.

Read SEC document
June 07, 2023 Filed Jun 8, 2023 21:10 UTC
Michaelson JenniferChief Development Officer
Exercise / conversionCommon Stock 100 $4.30 $430.00
Disclosure

SEC source: 0000950170-23-027063 · ownership.xml · nonDerivative · entry 3

Michaelson Jennifer · CIK 0001838061 · Chief Development Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 90,547

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 06, 2023 Filed Jun 8, 2023 21:10 UTC
Michaelson JenniferChief Development Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 11,900 $0.00 Strike: $4.30 $0.00
Disclosure

SEC source: 0000950170-23-027063 · ownership.xml · derivative · entry 5

Michaelson Jennifer · CIK 0001838061 · Chief Development Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 188,693

Underlying: Common Stock · 11,900 shares

Expires 2030-10-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: 25% of the shares vested on July 4, 2020, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.

Read SEC document
June 06, 2023 Filed Jun 8, 2023 21:10 UTC
Michaelson JenniferChief Development Officer
SaleCommon Stock 11,900 $12.31 $146,489.00
Disclosure

SEC source: 0000950170-23-027063 · ownership.xml · nonDerivative · entry 2

Michaelson Jennifer · CIK 0001838061 · Chief Development Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 90,447

F1 · kind: Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on April 29, 2021, as amended on June 24, 2022.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $12.30 to $12.35. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 06, 2023 Filed Jun 8, 2023 21:10 UTC
Michaelson JenniferChief Development Officer
Exercise / conversionCommon Stock 11,900 $4.30 $51,170.00
Disclosure

SEC source: 0000950170-23-027063 · ownership.xml · nonDerivative · entry 1

Michaelson Jennifer · CIK 0001838061 · Chief Development Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 102,347

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 23, 2023 Filed May 24, 2023 20:36 UTC
AHMED NADIMDirector · President and CEO
SaleCommon Stock 707 $9.15 $6,469.05
Disclosure

SEC source: 0000950170-23-023939 · ownership.xml · nonDerivative · entry 1

AHMED NADIM · CIK 0001731193 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 116,581

F1 · shares: Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.

Read SEC document
May 18, 2023 Filed May 19, 2023 20:51 UTC
Michaelson JenniferChief Development Officer
SaleCommon Stock 239 $8.76 $2,093.64
Disclosure

SEC source: 0000899243-23-013364 · doc4.xml · nonDerivative · entry 1

Michaelson Jennifer · CIK 0001838061 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,447

F1 · shares: Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.

Read SEC document
May 18, 2023 Filed May 19, 2023 20:46 UTC
Jones Jeffrey AlanChief Medical Officer
SaleCommon Stock 394 $8.76 $3,451.44
Disclosure

SEC source: 0000899243-23-013361 · doc4.xml · nonDerivative · entry 1

Jones Jeffrey Alan · CIK 0001914647 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,824

F1 · shares: Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.

Read SEC document
May 18, 2023 Filed May 19, 2023 20:44 UTC
Trigilio JeffreyChief Financial Officer
SaleCommon Stock 399 $8.76 $3,495.24
Disclosure

SEC source: 0000899243-23-013358 · doc4.xml · nonDerivative · entry 1

Trigilio Jeffrey · CIK 0001838671 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,541

F1 · shares: Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.

Read SEC document
May 18, 2023 Filed May 19, 2023 20:45 UTC
SUMER JACQUELYN LChief Legal Officer
SaleCommon Stock 291 $8.76 $2,549.16
Disclosure

SEC source: 0000899243-23-013360 · doc4.xml · nonDerivative · entry 1

SUMER JACQUELYN L · CIK 0001844824 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,114

F1 · shares: Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.

Read SEC document
May 12, 2023 Filed May 16, 2023 21:36 UTC
Michaelson JenniferChief Development Officer
SaleCommon Stock 193 $8.78 $1,694.54
Disclosure

SEC source: 0000950170-23-022557 · ownership.xml · nonDerivative · entry 1

Michaelson Jennifer · CIK 0001838061 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,686

F1 · shares: Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.

Read SEC document
May 12, 2023 Filed May 16, 2023 21:28 UTC
Trigilio JeffreyChief Financial Officer
SaleCommon Stock 347 $8.78 $3,046.66
Disclosure

SEC source: 0000950170-23-022548 · ownership.xml · nonDerivative · entry 1

Trigilio Jeffrey · CIK 0001838671 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,940

F1 · shares: Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.

Read SEC document
April 25, 2023 Filed Apr 26, 2023 20:23 UTC
AHMED NADIMDirector · President and CEO
SaleCommon Stock 716 $10.59 $7,582.44
Disclosure

SEC source: 0000950170-23-014838 · ownership.xml · nonDerivative · entry 1

AHMED NADIM · CIK 0001731193 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 117,288

F1 · shares: Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.

Read SEC document
April 18, 2023 Filed Apr 20, 2023 20:38 UTC
Jones Jeffrey AlanChief Medical Officer
SaleCommon Stock 392 $10.71 $4,198.32
Disclosure

SEC source: 0000950170-23-013705 · ownership.xml · nonDerivative · entry 1

Jones Jeffrey Alan · CIK 0001914647 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,218

F1 · shares: Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.

Read SEC document
April 18, 2023 Filed Apr 20, 2023 20:34 UTC
Trigilio JeffreyChief Financial Officer
SaleCommon Stock 398 $10.71 $4,262.58
Disclosure

SEC source: 0000950170-23-013702 · ownership.xml · nonDerivative · entry 1

Trigilio Jeffrey · CIK 0001838671 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,287

F1 · shares: Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.

Read SEC document
April 18, 2023 Filed Apr 20, 2023 20:32 UTC
Michaelson JenniferChief Development Officer
SaleCommon Stock 238 $10.71 $2,548.98
Disclosure

SEC source: 0000950170-23-013701 · ownership.xml · nonDerivative · entry 1

Michaelson Jennifer · CIK 0001838061 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,879

F1 · shares: Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.

Read SEC document
April 18, 2023 Filed Apr 20, 2023 20:30 UTC
SUMER JACQUELYN LChief Legal Officer
SaleCommon Stock 290 $10.71 $3,105.90
Disclosure

SEC source: 0000950170-23-013697 · ownership.xml · nonDerivative · entry 1

SUMER JACQUELYN L · CIK 0001844824 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,405

F1 · shares: Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.

Read SEC document
April 12, 2023 Filed Apr 14, 2023 22:35 UTC
Trigilio JeffreyChief Financial Officer
SaleCommon Stock 318 $10.22 $3,249.96
Disclosure

SEC source: 0000899243-23-011298 · doc4.xml · nonDerivative · entry 1

Trigilio Jeffrey · CIK 0001838671 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,685

F1 · shares: Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.

Read SEC document
April 12, 2023 Filed Apr 14, 2023 22:23 UTC
Michaelson JenniferChief Development Officer
SaleCommon Stock 176 $10.22 $1,798.72
Disclosure

SEC source: 0000899243-23-011292 · doc4.xml · nonDerivative · entry 1

Michaelson Jennifer · CIK 0001838061 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 91,117

F1 · shares: Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.

Read SEC document
March 23, 2023 Filed Mar 27, 2023 20:05 UTC
AHMED NADIMDirector · President and CEO
SaleCommon Stock 706 $10.51 $7,420.06
Disclosure

SEC source: 0000899243-23-009714 · doc4.xml · nonDerivative · entry 1

AHMED NADIM · CIK 0001731193 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 118,004

F1 · shares: Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.

Read SEC document
March 20, 2023 Filed Mar 27, 2023 20:05 UTC
Trigilio JeffreyChief Financial Officer
SaleCommon Stock 399 $11.32 $4,516.68
Disclosure

SEC source: 0000899243-23-009718 · doc4.xml · nonDerivative · entry 1

Trigilio Jeffrey · CIK 0001838671 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 88,003

F1 · shares: Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.

Read SEC document
March 20, 2023 Filed Mar 27, 2023 20:05 UTC
Jones Jeffrey AlanChief Medical Officer
SaleCommon Stock 390 $11.32 $4,414.80
Disclosure

SEC source: 0000899243-23-009717 · doc4.xml · nonDerivative · entry 1

Jones Jeffrey Alan · CIK 0001914647 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,610

F1 · shares: Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.

Read SEC document
March 20, 2023 Filed Mar 27, 2023 20:05 UTC
Michaelson JenniferChief Development Officer
SaleCommon Stock 238 $11.32 $2,694.16
Disclosure

SEC source: 0000899243-23-009716 · doc4.xml · nonDerivative · entry 1

Michaelson Jennifer · CIK 0001838061 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 91,293

F1 · shares: Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.

Read SEC document
March 20, 2023 Filed Mar 27, 2023 20:05 UTC
SUMER JACQUELYN LChief Legal Officer
SaleCommon Stock 305 $11.32 $3,452.60
Disclosure

SEC source: 0000899243-23-009715 · doc4.xml · nonDerivative · entry 1

SUMER JACQUELYN L · CIK 0001844824 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,695

F1 · shares: Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.

Read SEC document
February 22, 2023 Filed Feb 23, 2023 22:06 UTC
AHMED NADIMDirector · President and CEO
GrantStock Option (Right to Buy) · Derivative 211,000 $0.00 Strike: $11.03 $0.00
Disclosure

SEC source: 0000899243-23-006004 · doc4.xml · derivative · entry 2

AHMED NADIM · CIK 0001731193 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 211,000

Underlying: Common Stock · 211,000 shares

Expires 2033-02-21

F2 · derivative.exercise_date: The shares underlying the option vest over four years, with one forty-eighth (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date.

Read SEC document
February 22, 2023 Filed Feb 23, 2023 22:06 UTC
AHMED NADIMDirector · President and CEO
GrantCommon Stock 109,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-23-006004 · doc4.xml · nonDerivative · entry 1

AHMED NADIM · CIK 0001731193 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 118,710

F1 · shares: The shares underlying the restricted stock unit vest over four years, with one forty-eighth (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date.

Read SEC document
February 17, 2023 Filed Feb 21, 2023 18:53 UTC
Baeuerle PatrickChief Scientific Officer
GrantStock Option (Right to Buy) · Derivative 77,000 $0.00 Strike: $11.34 $0.00
Disclosure

SEC source: 0000899243-23-005731 · doc4.xml · derivative · entry 3

Baeuerle Patrick · CIK 0001362054 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,000

Underlying: Common Stock · 77,000 shares

Expires 2033-02-16

F3 · derivative.exercise_date: The shares underlying the option vest over four years, with one forty-eighth (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date.

Read SEC document
February 17, 2023 Filed Feb 21, 2023 18:53 UTC
Baeuerle PatrickChief Scientific Officer
GrantCommon Stock 38,500 $0.00 $0.00
Disclosure

SEC source: 0000899243-23-005731 · doc4.xml · nonDerivative · entry 1

Baeuerle Patrick · CIK 0001362054 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,000

F1 · shares: The shares underlying the restricted stock unit vest over four years, with one forty-eighth (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date.

Read SEC document
February 17, 2023 Filed Feb 22, 2023 00:01 UTC
Trigilio JeffreyChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 93,500 $0.00 Strike: $11.34 $0.00
Disclosure

SEC source: 0000899243-23-005736 · doc4.xml · derivative · entry 2

Trigilio Jeffrey · CIK 0001838671 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,500

Underlying: Common Stock · 93,500 shares

Expires 2033-02-16

F2 · derivative.exercise_date: The shares underlying the option vest over four years, with one forty-eighth (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date.

Read SEC document
February 17, 2023 Filed Feb 22, 2023 00:01 UTC
Trigilio JeffreyChief Financial Officer
GrantCommon Stock 47,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-23-005736 · doc4.xml · nonDerivative · entry 1

Trigilio Jeffrey · CIK 0001838671 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,402

F1 · shares: The shares underlying the restricted stock unit vest over four years, with one forty-eighth (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date.

Read SEC document
February 17, 2023 Filed Feb 21, 2023 23:57 UTC
Savill CorrineChief Business Officer
GrantStock Option (Right to Buy) · Derivative 41,000 $0.00 Strike: $11.34 $0.00
Disclosure

SEC source: 0000899243-23-005735 · doc4.xml · derivative · entry 2

Savill Corrine · CIK 0001837524 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,000

Underlying: Common Stock · 41,000 shares

Expires 2033-02-16

F2 · derivative.exercise_date: The shares underlying the option vest over four years, with one forty-eighth (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date.

Read SEC document
February 17, 2023 Filed Feb 21, 2023 23:57 UTC
Savill CorrineChief Business Officer
GrantCommon Stock 20,500 $0.00 $0.00
Disclosure

SEC source: 0000899243-23-005735 · doc4.xml · nonDerivative · entry 1

Savill Corrine · CIK 0001837524 · Chief Business Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 170,115

F1 · shares: The shares underlying the restricted stock unit vest over four years, with one forty-eighth (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.